Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | TSHR | P16473 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 7/20 | 0.41 |
| ▸ | PPARD | Q03181 | 7/20 | 0.41 |
| ▸ | PPARA | Q07869 | 7/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.41 |
| ▸ | TLR2 | O60603 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | FABP4 | P15090 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27637184 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| Ammonia Solution, Strong SCHEMBL28915466 | 0.98 | ALDH1A1 (0.50) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| Ammonia Solution, Strong SCHEMBL15769500 | 0.98 | ALDH1A1 (0.50) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL11707156 | 0.94 | ALDH1A1 (0.50) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL28077099 | 0.94 | ALDH1A1 (0.50) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| Hydrochloric Acid SCHEMBL29226163 | 0.92 | ALDH1A1 (0.48) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| Hydrochloric Acid SCHEMBL29226164 | 0.92 | ALDH1A1 (0.48) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL27082428 | 0.92 | ALDH1A1 (0.48) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL8333108 | 0.87 | ALDH1A1 (0.56) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL2312951 | 0.87 | ALDH1A1 (0.56) | ALDH1A1TSHRLMNANFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117903367-A | Modified starch filtrate reducer for drilling fluid, preparation method thereof and drilling fluid | 中国石油化工股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-115876898-A | Preparation and purity determination method of polyethylene glycol modifier | 长沙创新药物工业技术研究院有限公司 | 2023-03-31 | — | — | CN | claimed |
| US-9968538-B2 | Methods for treating skin | AVON PRODUCTS, INC. (US) | 2018-05-15 | — | — | US | claimed |
| US-20170143607-A1 | METHODS FOR TREATING SKIN | AVON PRODUCTS, INC. | 2017-05-25 | — | — | US | claimed |
| US-6096125-A | Ink compositions | XEROX CORPORATION (US) | 2000-08-01 | — | — | US | claimed |
| CN-119192563-A | Polyether amide synergist | 赢创运营有限公司 | 2024-12-27 | — | — | CN | disclosed |
| US-12151014-B2 | Gloss lip balm formulation | MAST INDUSTRIES (FAR EAST) LIMITED (CN) | 2024-11-26 | — | — | US | disclosed |
| US-20240374497-A1 | COMPOSITIONS COMPRISING OR2AT4 AGONISTS | COTY INC. | 2024-11-14 | — | — | US | disclosed |
| CN-118871088-A | Compositions comprising OR2AT4 agonists | 科蒂公司 | 2024-10-29 | — | — | CN | disclosed |
| EP-4408540-A1 | COMPOSITIONS COMPRISING OR2AT4 AGONISTS | Coty Inc. (US) | 2024-08-07 | — | — | EP | disclosed |
| CN-110312730-B | Cytotoxins and conjugates, uses thereof and methods of preparation | 四川科伦博泰生物医药股份有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-117903367-A | Modified starch filtrate reducer for drilling fluid, preparation method thereof and drilling fluid | 中国石油化工股份有限公司 | 2024-04-19 | — | — | CN | disclosed |
| EP-0910331-A4 | OXA DIACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS | AVON PROD INC (US) | 1999-11-03 | — | — | EP | disclosed |
| US-5932229-A | TOPICAL COMPOUNDS | AVON PRODUCTS, INC. (US) | 1999-08-03 | — | — | US | disclosed |
| EP-0910331-A1 | OXA DIACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS | AVON PRODUCTS, INC. (US) | 1999-04-28 | — | — | EP | disclosed |
| US-5717054-A | QUICK-SETTING | NATIONAL STARCH & CHEMICAL INVESTMENT HOLDING CORP. (US) | 1998-02-10 | — | — | US | disclosed |
| WO-1997039726-A1 | OXA DIACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS | AVON PRODUCTS, INC. (US) | 1997-10-30 | — | — | WO | disclosed |
| EP-0747371-A1 | Epoxy resins consisting of flexible chains terminated with glycidyloxyphenyl groups for use in microelectronics adhesives | National Starch and Chemical Investment Holding Corporation (US) | 1996-12-11 | — | — | EP | disclosed |
| US-5108628-A | Aliphatic ether carboxylic acid amidoamines as an anionic optical brightener | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1992-04-28 | — | — | US | disclosed |
| US-4001298-A | RADIOPAQUE AGENTS | SCHERING AKTIENGESELLSCHAFT (DT) | 1977-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12151014-B2 | Gloss lip balm formulation | PLIN5, GLB1, ALG3 | ALDH1A1 2603/4885TSHR 3878/4885LMNA 47/4885 |
| US-20240374497-A1 | COMPOSITIONS COMPRISING OR2AT4 AGONISTS | AREG, FFAR4, HTR2A | ALDH1A1 2026/4885TSHR 201/4885LMNA 4404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.